The disposition of sodium fusidate in man
- PMID: 911608
- PMCID: PMC1429160
- DOI: 10.1111/j.1365-2125.1977.tb00795.x
The disposition of sodium fusidate in man
Abstract
1 In a pharmacokinetic study in six volunteers serum fusidic acid concentrations were obtained after rapid intravenous administration of 100 mg. 2 Analysis of the data suggests that the serum concentration/time curve is biphasic and that the curve can be described by the following equation: cp=5.9e(-1.82t)+4.3e(-0.13t). 3 The disposition characteristics of sodium fusidate have been calculated from this relationship and a plasma half life for sodium fusidate of between 5 and 6 h obtained. 4 Subsequently plasma fusidic acid levels have been measured in the same volunteers on three occasions after sodium fusidate (500 mg) given either as a slow intravenous infusion, or orally as a capsule or as a suspension. 5 Serum levels and AUC after a capsule were about 75% of those obtained after the infusion (30 and 70 mg/1 at peak respectively) whereas levels and AUC after the suspension were only about 50%.
Similar articles
-
Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation.J Antimicrob Chemother. 1990 Feb;25 Suppl B:23-31. doi: 10.1093/jac/25.suppl_b.23. J Antimicrob Chemother. 1990. PMID: 2312443
-
Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.Antimicrob Agents Chemother. 2013 Jan;57(1):498-507. doi: 10.1128/AAC.01354-12. Epub 2012 Nov 12. Antimicrob Agents Chemother. 2013. PMID: 23147726 Free PMC article.
-
Drug-cholestyramine interactions. II. Influence of cholestyramine on GI absorption of sodium fusidate.J Pharm Sci. 1972 May;61(5):735-9. doi: 10.1002/jps.2600610513. J Pharm Sci. 1972. PMID: 5035781 No abstract available.
-
Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension.J Clin Pharm Ther. 1993 Jun;18(3):171-7. doi: 10.1111/j.1365-2710.1993.tb00608.x. J Clin Pharm Ther. 1993. PMID: 8345001 Clinical Trial.
-
Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers.J Antimicrob Chemother. 1989 Mar;23(3):409-15. doi: 10.1093/jac/23.3.409. J Antimicrob Chemother. 1989. PMID: 2732122
Cited by
-
Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci.J Clin Microbiol. 1995 Jul;33(7):1712-5. doi: 10.1128/jcm.33.7.1712-1715.1995. J Clin Microbiol. 1995. PMID: 7665633 Free PMC article.
-
Susceptibility of mycobacteria to fusidic acid.Eur J Clin Microbiol Infect Dis. 1990 Apr;9(4):294-7. doi: 10.1007/BF01968066. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2112466
-
Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers.Eur J Drug Metab Pharmacokinet. 1994 Oct-Dec;19(4):337-41. doi: 10.1007/BF03188860. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7737235
-
Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.Antimicrob Agents Chemother. 1985 Jun;27(6):928-32. doi: 10.1128/AAC.27.6.928. Antimicrob Agents Chemother. 1985. PMID: 4026265 Free PMC article.
-
Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.Antimicrob Agents Chemother. 1993 Mar;37(3):501-6. doi: 10.1128/AAC.37.3.501. Antimicrob Agents Chemother. 1993. PMID: 8460918 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous